BTTAY
Price:
$24.23
Market Cap:
$1.58B
Operating globally from its headquarters in Dreieich, Germany, Biotest AG is a pharmaceutical company established in 1946. It specializes in the research, development, manufacturing, and commercialization of biological medicines. The company's operations are structured across its Therapy, Plasma & Services, and Other divisions. Biotest's product portfolio addresses critical needs within hematology, clinical immunology, and intensive care medicine. For instance, Biotest provides treatments for hemophilia, including Haemoctin and Vihuma for hemophilia A, and Haemonine for hemophilia B, addressing both acute episodes and long-term prevention. Its infectious disease portfolio features therapies ...[Read more]
Industry
Biotechnology
IPO Date
2022-08-08
Stock Exchange
OTC
Ticker
BTTAY
According to Biotest AG’s latest financial reports and current stock price. The company's current PE Ratio is -67.31. This represents a change of 220.31% compared to the average of -21.01 of the last 4 quarters.
The mean historical PE Ratio of Biotest AG over the last ten years is -46.39. The current -67.31 PE Ratio has changed 14.41% with respect to the historical average. Over the past ten years (40 quarters), BTTAY's PE Ratio was at its highest in in the December 2020 quarter at 679.98. The PE Ratio was at its lowest in in the March 2019 quarter at -184.25.
Average
-46.39
Median
-17.83
Minimum
-225.67
Maximum
40.47
Discovering the peaks and valleys of Biotest AG PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.85%
Maximum Annual PE Ratio = 40.47
Minimum Annual Increase = -3472.43%
Minimum Annual PE Ratio = -225.67
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | 40.47 | 316.30% |
| 2023 | 9.72 | -122.91% |
| 2022 | -42.44 | 76.17% |
| 2021 | -24.09 | -31.97% |
| 2020 | -35.41 | -79.48% |
| 2019 | -172.60 | -3472.43% |
| 2018 | 5.12 | -102.27% |
| 2017 | -225.67 | 1.85% |
| 2016 | -11.57 | 56.62% |
| 2015 | -7.39 | -111.44% |
The current PE Ratio of Biotest AG (BTTAY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
2.58
5-year avg
-10.35
10-year avg
-46.39
Biotest AG’s PE Ratio is less than Kaken Pharmaceutical Co., Ltd. (67.59), less than Luye Pharma Group Ltd. (10.57), less than Inventiva S.A. (-6.15), less than Kossan Rubber Industries Bhd (18.74), less than China Shineway Pharmaceutical Group Limited (5.58), less than Opthea Limited (-6.41), less than Claritas Pharmaceuticals, Inc. (0.00), less than Oxurion N.V. (-0.02), less than EBR Systems, Inc. (-21.89), less than Kindstar Globalgene Technology, Inc. (-15.12),
| Company | PE Ratio | Market cap |
|---|---|---|
| 67.59 | $984.58M | |
| 10.57 | $815.28M | |
| -6.15 | $741.20M | |
| 18.74 | $839.59M | |
| 5.58 | $758.42M | |
| -6.41 | $13.68M | |
| 0.00 | $3.66K | |
| -0.02 | $433.72M | |
| -21.89 | $139.51M | |
| -15.12 | $675.13M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Biotest AG using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Biotest AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Biotest AG's PE Ratio?
How is the PE Ratio calculated for Biotest AG (BTTAY)?
What is the highest PE Ratio for Biotest AG (BTTAY)?
What is the 3-year average PE Ratio for Biotest AG (BTTAY)?
What is the 5-year average PE Ratio for Biotest AG (BTTAY)?
How does the current PE Ratio for Biotest AG (BTTAY) compare to its historical average?